A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience

Published:2019-01-01 Issue:1 Volume:26 Page:384-392
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

van den Bemt Bart J. F.¹²,Gettings Lynda³,Domańska Barbara⁴,Bruggraber Richard⁴,Mountian Irina⁵,Kristensen Lars E.⁶

Affiliation:

1. Department of Pharmacy, Sint Maartenskliniek, Ubbergen, The Netherlands;

2. Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands;

3. Insight - Cell to Psychology, Durham, UK;

4. UCB Pharma, Slough, UK;

5. UCB Pharma, Brussels, Belgium;

6. The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark

Funder

UCB

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2019.1587043

Reference88 articles.

1. An ingestible self-orienting system for oral delivery of macromolecules

2. Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study

4. Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

5. Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acceptability of CYLTEZO pen among biologics autoinjector patients, autoinjector Naïve patients, and healthcare professionals;Expert Opinion on Drug Delivery;2024-08-28

2. Retention rate of a novel autoinjector e-Device introduced to patients with chronic arthritis treated with certolizumab pegol in clinical practice: an observational implementation study;Scandinavian Journal of Rheumatology;2024-07-08

3. Postmarketing Reports of Incomplete Dosing-Related Complications with Self-Injected PCSK9 Inhibitors: A Descriptive Study and Disproportionality Analysis;BioDrugs;2024-06-14

4. Rose Bengal Labeled Bovine Serum Albumin for Protein Transport Imaging in Subcutaneous Tissues Using Computed Tomography and Fluorescence Microscopy;Bioconjugate Chemistry;2024-06-14

5. Towards more tolerable subcutaneous administration: Review of contributing factors for improving combination product design;Advanced Drug Delivery Reviews;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3